Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564831 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
A NA study of Diabetic Foot Ulcer and Diabetic Foot, sponsored by Applied Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT06564831: Recruiting NA study of Diabetic Foot Ulcer and Diabetic Foot, sponsored by Applied Biologics.
NCT06564831 is a NA study of Diabetic Foot Ulcer and Diabetic Foot that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 124 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564831, a NA study of Diabetic Foot Ulcer and Diabetic Foot, is actively recruiting participants, sponsored by Applied Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers
Primary Outcome
The percentage of target ulcers achieving complete wound closure in 12 weeks.
Conditions Studied
Interventions
- OTHER SOC
- OTHER SLAM + SOC
Study Locations (1)
Michigan
- Detroit Foot and Ankle - Clinton Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-08 |
| Phase | NA |
What NCT06564831 shows while recruiting
NCT06564831 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (51% lower).
The record links to 5 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which SOC is the first listed.
NCT06564831 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06564831 about?
NCT06564831 is a clinical study titled "Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care". A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers
What is the current status of trial NCT06564831?
This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2024-09-20. Estimated completion is 2025-08.
What conditions does trial NCT06564831 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer, Ulcer Foot, DFU.
What interventions are being tested in trial NCT06564831?
The interventions under investigation include: SOC (OTHER), SLAM + SOC (OTHER).
Who is sponsoring clinical trial NCT06564831?
This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564831 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06564831's enrollment target sits among peer trials
124 31st of 67 higher than 37 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI